Viva Biotech Holdings Financial Health

Short Term Liabilities: 1873's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥1.1B).

Long Term Liabilities: 1873's short term assets (CN¥2.0B) do not cover its long term liabilities (CN¥3.1B).

Debt Level: 1873's net debt to equity ratio (52.6%) is considered high.

Reducing Debt: 1873's debt to equity ratio has increased from 3.7% to 70.7% over the past 5 years.

Debt Coverage: 1873's debt is not well covered by operating cash flow (5.5%).

Interest Coverage: 1873's interest payments on its debt are not well covered by EBIT (1.3x coverage).

• Healthy companies in the Pharmaceuticals & Biotech industry.